Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) President Amir Heshmatpour purchased 5,000 shares of the company’s stock in a transaction that occurred on Thursday, April 9th. The shares were acquired at an average price of $5.19 per share, for a total transaction of $25,950.00. Following the completion of the purchase, the president directly owned 3,032,000 shares in the company, valued at $15,736,080. This represents a 0.17% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Neonc Technologies Stock Performance
Shares of NTHI stock opened at $5.12 on Friday. The firm’s 50 day moving average is $8.64 and its 200 day moving average is $9.12. Neonc Technologies Holdings, Inc. has a 12 month low of $3.20 and a 12 month high of $12.99.
Analyst Ratings Changes
A number of analysts recently weighed in on NTHI shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a report on Friday, March 27th. Zacks Research raised shares of Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce”.
Institutional Trading of Neonc Technologies
Hedge funds and other institutional investors have recently bought and sold shares of the company. HighPoint Advisor Group LLC increased its holdings in Neonc Technologies by 424.8% during the 3rd quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock worth $8,628,000 after acquiring an additional 769,163 shares during the period. Global Retirement Partners LLC bought a new stake in shares of Neonc Technologies during the 3rd quarter worth $434,000. SLT Holdings LLC bought a new stake in shares of Neonc Technologies during the 3rd quarter worth $100,000. Bank of America Corp DE purchased a new position in Neonc Technologies in the second quarter worth $801,000. Finally, 683 Capital Management LLC bought a new position in Neonc Technologies in the fourth quarter valued at $442,000.
Neonc Technologies Company Profile
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Featured Stories
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
